You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股消息》藥師幫(09885.HK)明起招股 入場費約4,646元
阿思達克 06-14 16:42
內地醫藥產業服務平台藥師幫(09885.HK)公布招股詳情,計劃全球發售約1,580.88萬股,當中香港公開發售佔一成,國際發售佔九成,每股招股價介乎19至23元,集資最多約3.63億元。獨家保薦人為中金公司。 每手200股計入場費約4,646.39元,將於明日(15日)起招股,至下周二(20日)截止,預期將於28日掛牌。 是次上市引入中關村發展集團旗下ZGC International為基石投資者,認購約1,280萬美元等值股份,設六個月禁售期。 以招股價中位數每股21元計,集資淨額預期達2.54億元,所得資金約45%計劃用於醫藥流通業務;約25%用於拓展其他業務;約22%用於研發;餘下8%為營運資金及其他一般企業用途。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account